Germline Testing in Patients with Breast Cancer

Publication Date: January 4, 2024
Last Updated: January 4, 2024

Treatment

Recommendation 1.1

All patients newly diagnosed with breast cancer with stage I–III or de novo stage IV/metastatic disease who are 65 years of age or younger at diagnosis should be offered BRCA1/2 testing. (CB, , , )
1048203

Overview

Title

Germline Testing in Patients with Breast Cancer

Authoring Organizations